Naja sumatrana is the dominant cobra species in Malaysia, Singapore, Borneo, and Sumatra, and it does not have specific antivenom. The Haffkine antivenom has been advocated instead. This study aims to determine the efficacy of this antivenom against Naja sumatrana envenoming using a mouse model. Methods. Male Swiss albino mice were used. Intravenous LD50 was first determined separately for Naja naja and Naja sumatrana venom. ED50 was determined by preincubating antivenom with each venom at 2.5 LD50 before administering the mixture into the tail vein. Validation was carried out using a challenge test. Each mouse received 111 µg of Naja sumatrana venom intramuscularly followed by intraperitoneal administration of dilute Haffkine antivenom. Survival was recorded 24 hours after envenoming. Results. The LD50 of Naja naja venom was 78.13 µg, standard error (SE) 13.3 µg. The ED50 of the Haffkine antivenom against Naja naja venom was 45.9 mg, SE 7.5 mg. The LD50 and ED50 of Naja sumatrana venom were 55.5 µg, SE 12.0 µg; and 73.9 mg, SE 12.0 mg, respectively. The intra-peritoneal ED50 against 111 µg intramuscular Naja sumatrana venom was 136.95 mg, SE 36.74 mg. Conclusion. The Haffkine polyvalent antivenom exhibited cross-neutralisation against Naja sumatrana venom when used at a higher dose.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753748PMC
http://dx.doi.org/10.1155/2013/247645DOI Listing

Publication Analysis

Top Keywords

naja sumatrana
32
sumatrana venom
20
haffkine antivenom
16
naja naja
16
naja
13
sumatrana
8
antivenom
8
mouse model
8
antivenom naja
8
venom
8

Similar Publications

Snake envenomation poses a significant risk to Malaysians and country visitors. Malaysia witnesses an estimated 650 snake bites per 100,000 population annually. The primary treatment for snake envenomation involves administering antivenom derived from horses, despite its drawbacks, such as anaphylactic reactions and serum sickness.

View Article and Find Full Text PDF
Article Synopsis
  • Naja species bites are a leading cause of consultations for snake envenomation in Malaysia, often resulting in severe neuroparalytic and cardiotoxic effects.
  • A reported case highlighted a 14-year-old boy who experienced cardiotoxicity, evident through an abnormal ECG, following a bite from the equatorial spitting cobra, Naja sumatrana, before showing signs of paralysis.
  • Timely administration of antivenom led to the resolution of symptoms, emphasizing the importance of monitoring for cardiotoxicity in envenomation cases to ensure quick treatment.
View Article and Find Full Text PDF

This study investigated the clinical characteristics, treatments, and outcomes of envenomation involving cobra species in Thailand (, , and ). Data of patients who had been bitten by a cobra or inoculated via the eyes/skin in 2018-2021 were obtained from the Ramathibodi Poison Center. There were 1045 patients admitted during the 4-year study period (bite, n = 539; ocular/dermal inoculation, n = 506).

View Article and Find Full Text PDF

Global parameter optimisation and sensitivity analysis of antivenom pharmacokinetics and pharmacodynamics.

Toxicon

August 2023

Department of Engineering Mathematics, Ada Lovelace Building, University of Bristol, University Walk, Bristol, BS8 1TW, UK. Electronic address:

In recent years it has become possible to design snakebite antivenoms with diverse pharmacokinetic properties. Owing to the pharmacokinetic variability of venoms, the choice of antivenom scaffold may influence a treatment's neutralisation coverage. Computation offers a useful medium through which to assess the pharmacokinetics and pharmacodynamics of envenomation-treatment systems, as antivenoms with identical neutralising capacities can be simulated.

View Article and Find Full Text PDF

Description of a New Cobra ( Laurenti, 1768; Squamata, Elapidae) from China with Designation of a Neotype for .

Animals (Basel)

December 2022

Key Laboratory of the Ministry of Education for Ecology of Rare and Endangered Species and Environmental Protection, Guangxi Normal University, Guilin 541004, China.

Taxonomic frameworks for medically important species such as cobras (genus Laurenti, 1768; Squamata, Elapidae) are essential for the medical treatment of snake bites and accurate antivenin development. In this paper, we described the former populations recorded from China as a new species and designated a neotype for -based morphological and mitochondrial phylogenetic analysis. The new species .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!